Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC19 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | C16orf72 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | UBL5 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | KRTAP20-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | PARVA | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
mRNA | SUN3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | MYBL2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | ITGA1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | IGFBP6 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | CACNG5 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |